5-氟-2-(三氟甲氧基)苯胺 | 123572-63-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 5-氟-2-(三氟甲氧基)苯胺
• 英文名称: 5-fluoro-2-(trifluoromethoxy)aniline
• 英文别名: 2-trifluoromethoxy-5-fluoroaniline；5-fluoro-2-trifluoromethoxy-phenylamine
• CAS: 123572-63-4
• 化学式: C₇H₅F₄NO
• 分子量: 195.116
• InChiKey: AUJAYNLPYRARLU-UHFFFAOYSA-N

物化性质

• 沸点：
  187.8±35.0 °C(Predicted)
• 密度：
  1.431±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  6

安全信息

• 危险等级：
  6.1
• 海关编码：
  2922199090
• 危险性防范说明：
  P261,P280,P305+P351+P338,P304+P340,P405,P501
• 危险性描述：
  H302,H312,H315,H319,H335

反应信息

• 作为反应物：
  描述：

  5-氟-2-(三氟甲氧基)苯胺 在 硫酸 、 硝酸 、 铁粉 、 potassium carbonate 、 溶剂黄146 作用下， 以 二甲基亚砜 为溶剂， 反应 3.5h， 生成
  参考文献：
  名称：

  Synthesis and QSAR of Herbicidal 3-Pyrazolyl α,α,α-Trifluorotolyl Ethers

  摘要：

  Pyrazole nitrophenyl ethers (PPEs) were recently identified as a novel class of chemistry exerting herbicidal effects by inhibition of protoporphyrinogen IX oxidase. This area of chemistry has been extended to include herbicidal pyrazolyl fluorotolyl ethers. In these compounds, a trifluoromethyl group substitutes for the 4'-nitro group found in the original herbicides and in ''classical'' nitrodiphenyl ether hebicides. Fluoroanisole pyrazole ethers, in which a trifluoromethoxy group replaces the nitro group of diphenyl ether herbicides, are also described. The shift from 4'-nitro to 4'-trifluoromethyl substitution, which is conservative in terms of electrostatics, produced a novel class of herbicide with substantial pre-emergent activity on narrowleaf weed species. Quantitative structure/activity relationships obtained with respect to substitution on the pyrazole ring and at the 3'-position of the fluorotolyl moiety can be summarized effectively by comparative molecular field analysis. In general, 5-methanesulfonyl fluorotoluidide ethers were found to be most active.

  DOI：

  10.1021/jf9601978
• 作为产物：
  描述：

  4-三氟甲氧基氟苯 在 硫酸 、 硝酸 、 铁粉 、 溶剂黄146 作用下， 生成 5-氟-2-(三氟甲氧基)苯胺
  参考文献：
  名称：

  Synthesis and QSAR of Herbicidal 3-Pyrazolyl α,α,α-Trifluorotolyl Ethers

  摘要：

  Pyrazole nitrophenyl ethers (PPEs) were recently identified as a novel class of chemistry exerting herbicidal effects by inhibition of protoporphyrinogen IX oxidase. This area of chemistry has been extended to include herbicidal pyrazolyl fluorotolyl ethers. In these compounds, a trifluoromethyl group substitutes for the 4'-nitro group found in the original herbicides and in ''classical'' nitrodiphenyl ether hebicides. Fluoroanisole pyrazole ethers, in which a trifluoromethoxy group replaces the nitro group of diphenyl ether herbicides, are also described. The shift from 4'-nitro to 4'-trifluoromethyl substitution, which is conservative in terms of electrostatics, produced a novel class of herbicide with substantial pre-emergent activity on narrowleaf weed species. Quantitative structure/activity relationships obtained with respect to substitution on the pyrazole ring and at the 3'-position of the fluorotolyl moiety can be summarized effectively by comparative molecular field analysis. In general, 5-methanesulfonyl fluorotoluidide ethers were found to be most active.

  DOI：

  10.1021/jf9601978

文献信息

• [EN] alpha7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF-I<br/>[FR] MODULATEURS DU RÉCEPTEUR Alpha7 NICOTINIQUE D'ACÉTYLCHOLINE ET LEURS UTILISATIONS
  申请人：BIONOMICS LTD

  公开号：WO2014019023A1

  公开（公告）日：2014-02-06

  The present invention relates to chemical compounds of formula (I), with the substituents as described in the specification, useful in the positive modulation of the alpha 7 nicotinic acetylcholine receptor (α7 nAChR). The invention also relates to the use of these compounds in the treatment or prevention of a broad range of diseases in which the positive modulation of α7 nAChR is advantageous, including neurodegenerative and neuropsychiatric diseases and also neuropathic pain and inflammatory diseases.

  本发明涉及化学式（I）的化合物，其取代基如规范中所述，在正向调节α7尼古丁乙酰胆碱受体（α7 nAChR）中有用。该发明还涉及这些化合物在治疗或预防广泛范围的疾病中的应用，其中正向调节α7 nAChR是有利的，包括神经退行性和神经精神疾病，以及神经病性疼痛和炎症性疾病。
• Discovery of BNC375, a Potent, Selective, and Orally Available Type I Positive Allosteric Modulator of α7 nAChRs
  作者：Andrew J. Harvey、Thomas D. Avery、Laurent Schaeffer、Christophe Joseph、Belinda C. Huff、Rajinder Singh、Christophe Morice、Bruno Giethlen、Anton A. Grishin、Carolyn J. Coles、Peter Kolesik、Stéphanie Wagner、Emile Andriambeloson、Bertrand Huyard、Etienne Poiraud、Dharam Paul、Susan M. O’Connor

  DOI：10.1021/acsmedchemlett.9b00001

  日期：2019.5.9

  whereas Type II PAMs both increase channel response and delay receptor desensitization. Both Type I and Type II PAMs are reported in literature, but there are limited reports describing their structure-kinetic profile relationships. Here, we report a novel class of compounds with either Type I or Type II behavior that can be tuned by the relative stereochemistry around the central cyclopropyl ring: for example

  就其对通道动力学的影响而言，α7nAChRs的正变构调节剂（PAM）可能具有不同的特性。I型PAM会放大对乙酰胆碱的峰通道响应，但似乎不会影响通道脱敏动力学，而II型PAM会增加通道响应并延迟受体脱敏。I型和II型PAM均在文献中进行了报道，但很少有报道描述它们的结构动力学轮廓关系。在这里，我们报告了一类具有I型或II型行为的新型化合物，可以通过围绕中央环丙基环的相对立体化学进行调节：例如（R，R）-13（BNC375）及其具有RR立体化学的类似物I型PAM位于中央环丙基环周围，而具有SS立体化学的同一系列化合物（例如，（S，S）-13）是使用膜片钳电生理学测量的II型PAM。通过改变苯胺环上的取代基可实现对动力学的进一步精细控制：通常，苯胺被强吸电子基团取代会降低这些化合物的II型特性。我们通过结构活性优化工作发现了BNC375，这是一种具有良好CNS-药物样性质和临床候选潜力的小分子。
• [EN] DISUBSTITUTED [4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-1H-INDOL-3-YL]-METHANONES<br/>[FR] [4-(5-AMINOMÉTHYL-PHÉNYL)-PIPÉRIDIN-1-YL]-1H-INDOL-3-YL]-MÉTHANONES DISUBSTITUÉES
  申请人：SANOFI AVENTIS

  公开号：WO2011022449A1

  公开（公告）日：2011-02-24

  The present invention extends to the compound of formula I: or a prodrug, pharmaceutically acceptable salt, or solvate of said compound. Furthermore, the present invention is directed to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula I, and a pharmaceutically acceptable carrier. Furthermore, the present invention is directed to the use of a compound of formula I as an inhibitor of tryptase, comprising introducing the compound into a composition comprising tryptase. In addition, the present invention is directed to the use of a compound of formula I for treating a patient suffering from, or subject to, a physiological condition in need of amelioration of an inhibitor of tryptase comprising administering to the patient a therapeutically effective amount of the compound of Claim 1. The present invention is directed also to the preparation of a compound of formula I.

  本发明涉及到式I的化合物：或者该化合物的前药、药用可接受的盐或溶剂。此外，本发明涉及一种包括式I化合物的药物组合物，以及药用可接受的载体的药学有效量。此外，本发明涉及将式I化合物用作色氨酸蛋白酶抑制剂的用途，包括将该化合物引入含有色氨酸蛋白酶的组合物中。此外，本发明还涉及将式I化合物用于治疗患有或患有需要改善色氨酸蛋白酶抑制剂的生理状况的患者的用途，包括向患者施用权利要求1中的化合物的治疗有效量。本发明还涉及制备式I化合物。
• Diaminotriazoles useful as inhibitors of protein kinases
  申请人：——

  公开号：US20040214817A1

  公开（公告）日：2004-10-28

  The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及蛋白激酶抑制剂。本发明还提供了包含本发明化合物的制药组合物以及使用该组合物治疗各种疾病的方法。
• DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES
  申请人：Pierce C. Albert

  公开号：US20080014189A1

  公开（公告）日：2008-01-17

  The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及蛋白激酶抑制剂。该发明还提供了包含本发明化合物的药物组合物以及使用该组合物治疗各种疾病的方法。